There's something particularly frustrating about this overlap — not just medically, but emotionally. Women in perimenopause are already used to having their symptoms minimized or attributed to hormones, and celiac disease carries its own long history of being dismissed as 'just a sensitive stomach.' When both are happening at once, the result can be a decade of exhaustion that everyone around you treats as inevitable. It isn't.
Learn more about Rose →Estrogen withdrawal genuinely impairs verbal memory and processing speed, giving clinicians a ready explanation when a woman in her late 40s reports mental cloudiness. What gets missed is that celiac disease independently causes cognitive dysfunction through chronic neuroinflammation, nutrient malabsorption (particularly B12, folate, and iron), and a disrupted gut-brain axis — even in the absence of obvious gastrointestinal symptoms. Studies in newly diagnosed adult celiac patients show measurable improvements in cognitive performance after 12 months on a gluten-free diet, suggesting the brain fog had a nutritional and inflammatory component all along.
Estrogen decline after menopause drives osteoclast activity upward, producing well-documented bone mineral density loss that clinicians expect and monitor. Undiagnosed celiac disease adds a second, compounding mechanism: malabsorption of calcium and vitamin D in a damaged small intestine means the raw materials for bone remodeling are simply not arriving, regardless of how much dairy or supplemental calcium a woman consumes. Research consistently shows that celiac patients have significantly lower bone density than matched controls, and that a gluten-free diet partially — but not fully — reverses this loss, meaning the window for intervention matters enormously.
Perimenopausal women often experience iron-deficiency anemia because of heavier, irregular bleeding during the menstrual transition — a pattern so common it rarely prompts investigation beyond a CBC and a recommendation to eat more red meat. Celiac disease causes iron deficiency through a completely different route: the proximal small intestine, where iron absorption primarily occurs, is the section most severely damaged by gluten-triggered immune attack, so absorption is impaired even with adequate dietary intake. When anemia persists or fails to correct despite treatment, celiac disease screening with tissue transglutaminase IgA (tTG-IgA) antibodies should be on the table.
The fatigue of perimenopause is real and has multiple physiological drivers: disrupted sleep from vasomotor symptoms, HPA axis dysregulation, and the direct energetic effects of fluctuating estrogen and progesterone. Celiac disease fatigue operates through overlapping but distinct pathways — systemic inflammation, mitochondrial impairment linked to nutrient deficiencies, and the metabolic cost of chronic immune activation in the gut. Because both fatigues present identically to the woman experiencing them and to the clinician observing her, the celiac component is routinely absorbed into a menopause diagnosis without further investigation.
Progesterone's metabolite allopregnanolone is a potent modulator of GABA receptors, so its decline in perimenopause produces measurable increases in anxiety, irritability, and emotional lability through well-characterized neurochemical pathways. Celiac disease contributes to mood instability through gut microbiome disruption, systemic inflammation affecting the blood-brain barrier, and deficiencies in tryptophan metabolism — the precursor pathway for serotonin synthesis — that emerge when small intestinal absorption is compromised. Clinical studies have found elevated rates of anxiety and depression in undiagnosed celiac patients, which partially resolve on a strict gluten-free diet, a recovery trajectory that no hormone intervention alone would produce.
Perimenopause does alter gut motility: declining estrogen and progesterone affect the enteric nervous system, and many women notice new bloating, constipation, or changes in bowel habits during the transition that are genuinely hormone-related. This creates a clinical blind spot where celiac-driven symptoms — bloating, diarrhea, abdominal cramping, and altered stool consistency — are folded into a 'hormones are affecting your gut' explanation without further workup. The critical distinction is that celiac gastrointestinal symptoms are triggered specifically by gluten exposure and involve immune-mediated mucosal damage, not just motility changes — a difference that dietary pattern observation and antibody testing can help clarify.
Tingling, numbness, or burning sensations in the hands and feet are recognized but underappreciated neurological manifestations of celiac disease, occurring even in patients with minimal gastrointestinal symptoms and driven primarily by B12, B6, and copper deficiency from malabsorption, as well as direct gluten-related neurological autoimmunity. In perimenopausal women, these same sensations are often attributed to age-related nerve changes, carpal tunnel syndrome from fluid retention, or — when they occur as paresthesias during hot flashes — simply to vasomotor events. The distinction matters because celiac neuropathy can progress silently and irreversibly if gluten exposure continues, while the menopause-related sensations typically respond to vasomotor treatment.
Autoimmune thyroid disease — particularly Hashimoto's thyroiditis — is significantly more common in women with celiac disease than in the general population, and the thyroid dysfunction it causes (fatigue, weight changes, cognitive slowing, mood disturbance) overlaps almost completely with both menopause and celiac symptom profiles. A woman entering perimenopause with undiagnosed celiac disease may also be developing Hashimoto's thyroiditis, creating a three-way symptom tangle where each condition's contribution is invisible because the whole picture looks like textbook menopause. Celiac disease screening in women with autoimmune thyroid conditions, and vice versa, is supported by evidence of shared genetic predisposition on the HLA-DQ2/DQ8 loci.
The average diagnostic delay for celiac disease in adults is still estimated at six to ten years from symptom onset, and women in their 40s and 50s face a specific additional barrier: a plausible, socially normalized explanation (menopause) is already in place when they present to a clinician. Research on diagnostic patterns shows that adult women with celiac disease are more likely to present with extraintestinal symptoms — bone disease, anemia, neurological symptoms, mood disorders — than with classic diarrhea, which means the stereotypical celiac presentation that would prompt testing often isn't the one that actually appears. The practical implication is that any woman whose menopause symptoms don't respond proportionally to appropriate hormone or lifestyle treatment deserves celiac antibody screening as a standard next step, not an afterthought.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.